Trial
NCT04063865
Everolimus Monotherapy as Immunosuppression After Liver Transplant
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Indiana University
Collaborators
—
Condition
Kidney Failure
Intervention
Tacrolimus
Why stopped
Study was larger than expected and became a burden to faculty and staff resources.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-23